Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 3814-3817, July 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pretlow, T. G.
Right arrow Articles by Pretlow, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pretlow, T. G.
Right arrow Articles by Pretlow, T. P.

Transplantation of Human Prostatic Carcinoma into Nude Mice in Matrigel1

Thomas G. Pretlow2, Carrie M. Delmoro, Ginny G. Dilley, Carmela G. Spadafora and Theresa P. Pretlow

Institute of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106

Previous successful transplantation of human primary prostatic carcinomas into nude mice has been described as "close to zero." When injected in Matrigel instead of culture medium, 25,000-fold fewer cells of the PC-3 human prostatic carcinoma cell line were required for the growth of tumors in nude mice during a 3-month period of observation; similar enhancement was observed with two other human prostatic carcinoma cell lines. Six of ten primary human prostatic carcinomas were transplanted successfully into nude mice when Matrigel was used as the vehicle.

1 This work was supported by NIH Grants CA48032, CA43703, and CA54031; Grant PDT-407 from the American Cancer Society; and Grant 89B48 from the American Institute for Cancer Research.

2 To whom requests for reprints should be addressed.

Received 4/22/91. Accepted 5/29/91.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
M. F. McEntee, C. Ziegler, D. Reel, K. Tomer, A. Shoieb, M. Ray, X. Li, N. Neilsen, F. B. Lih, D. O'Rourke, et al.
Dietary n-3 Polyunsaturated Fatty Acids Enhance Hormone Ablation Therapy in Androgen-Dependent Prostate Cancer
Am. J. Pathol., July 1, 2008; 173(1): 229 - 241.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C.-p. Chuu, R. A. Hiipakka, J. Fukuchi, J. M. Kokontis, and S. Liao
Androgen Causes Growth Suppression and Reversion of Androgen-Independent Prostate Cancer Xenografts to an Androgen-Stimulated Phenotype in Athymic Mice
Cancer Res., March 15, 2005; 65(6): 2082 - 2084.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. C. Polek, L. V. Stewart, E. J. Ryu, M. B. Cohen, E. A. Allegretto, and N. L. Weigel
p53 Is Required for 1,25-Dihydroxyvitamin D3-Induced G0 Arrest But Is Not Required for G1 Accumulation or Apoptosis of LNCaP Prostate Cancer Cells
Endocrinology, January 1, 2003; 144(1): 50 - 60.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. M. Sirotnak, Y. She, F. Lee, J. Chen, and H. I. Scher
Studies with CWR22 Xenografts in Nude Mice Suggest That ZD1839 May Have a Role in the Treatment of Both Androgen-dependent and Androgen-independent Human Prostate Cancer
Clin. Cancer Res., December 1, 2002; 8(12): 3870 - 3876.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. A. Tuxhorn, S. J. McAlhany, T. D. Dang, G. E. Ayala, and D. R. Rowley
Stromal Cells Promote Angiogenesis and Growth of Human Prostate Tumors in a Differential Reactive Stroma (DRS) Xenograft Model
Cancer Res., June 1, 2002; 62(11): 3298 - 3307.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. D. Zapata, R. M. Ropero, A. M. Valencia, L. Buscail, J. I. Lopez, R. M. Martin-Orozco, J. C. Prieto, J. Angulo, C. Susini, P. Lopez-Ruiz, et al.
Autocrine Regulation of Human Prostate Carcinoma Cell Proliferation by Somatostatin through the Modulation of the SH2 Domain Containing Protein Tyrosine Phosphatase (SHP)-1
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 915 - 926.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Asamoto, N. Hokaiwado, Y.-M. Cho, S. Takahashi, Y. Ikeda, K. Imaida, and T. Shirai
Prostate Carcinomas Developing in Transgenic Rats with SV40 T Antigen Expression under Probasin Promoter Control Are Strictly Androgen Dependent
Cancer Res., June 1, 2001; 61(12): 4693 - 4700.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. G. Pretlow, S. Schwartz, J. M. Giaconia, A. L. Wright, H. A. Grimm, N. L. Edgehouse, J. R. Murphy, S. D. Markowitz, J. M. Jamison, J. L. Summers, et al.
Prostate Cancer and Other Xenografts from Cells in Peripheral Blood of Patients
Cancer Res., August 1, 2000; 60(15): 4033 - 4036.
[Abstract] [Full Text]


Home page
J. Histochem. Cytochem.Home page
J. L. Holleran, C. J. Miller, and L. A. Culp
Tracking Micrometastasis to Multiple Organs with lacZ-tagged CWR22R Prostate Carcinoma Cells
J. Histochem. Cytochem., May 1, 2000; 48(5): 643 - 652.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.